206 related articles for article (PubMed ID: 34668649)
1. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging for breast cancer detection: An update meta-analysis.
Dong H; Kang L; Cheng S; Zhang R
Thorac Cancer; 2021 Dec; 12(23):3201-3207. PubMed ID: 34668649
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis.
Zhang L; Tang M; Min Z; Lu J; Lei X; Zhang X
Acta Radiol; 2016 Jun; 57(6):651-60. PubMed ID: 26275624
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of contrast-enhanced spectral mammography versus MRI in the diagnosis of breast cancer.
Xiang W; Rao H; Zhou L
Thorac Cancer; 2020 Jun; 11(6):1423-1432. PubMed ID: 32233072
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of Contrast-Enhanced Ultrasonography With SonoVue in the Differentiation of Benign and Malignant Breast Lesions: A Meta-Analysis.
Lu J; Zhou P; Jin C; Xu L; Zhu X; Lian Q; Gong X
Technol Cancer Res Treat; 2020; 19():1533033820971583. PubMed ID: 33308040
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Efficacy of Serum 1,3-β-D-glucan for Invasive Fungal Infection: An Update Meta-Analysis Based on 37 Case Or Cohort Studies.
Xiaoling L; Tingyu T; Caibao H; Tian Z; Changqin C
Open Med (Wars); 2018; 13():329-337. PubMed ID: 30211316
[TBL] [Abstract][Full Text] [Related]
6. Can supplementary contrast-enhanced MRI of the breast avoid needle biopsies in suspicious microcalcifications seen on mammography? A systematic review and meta-analysis.
Fueger BJ; Clauser P; Kapetas P; Pötsch N; Helbich TH; Baltzer PAT
Breast; 2021 Apr; 56():53-60. PubMed ID: 33618160
[TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis of Quantitative Dynamic Contrast-Enhanced MRI for the Assessment of Neoadjuvant Chemotherapy in Breast Cancer.
Jun W; Cong W; Xianxin X; Daqing J
Am Surg; 2019 Jun; 85(6):645-653. PubMed ID: 31267907
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of diffusion-weighted imaging combined with dynamic contrast-enhanced magnetic resonance imaging for prostate cancer: a systematic review and meta-analysis.
Yang L; Tan Y; Dan H; Hu L; Zhang J
Acta Radiol; 2021 Sep; 62(9):1238-1247. PubMed ID: 32903025
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging for malignant ovarian tumors: a systematic review and meta-analysis.
Wei M; Bo F; Cao H; Zhou W; Shan W; Bai G
Acta Radiol; 2021 Jul; 62(7):966-978. PubMed ID: 32741199
[TBL] [Abstract][Full Text] [Related]
10. The assessment of pathological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer patients with DCE-MRI and DWI: a systematic review and meta-analysis.
Zong R; Ma X; Shi Y; Geng L
Br J Radiol; 2023 Oct; 96(1150):20230239. PubMed ID: 37660472
[TBL] [Abstract][Full Text] [Related]
11. Potential of Noncontrast Magnetic Resonance Imaging With Diffusion-Weighted Imaging in Characterization of Breast Lesions: Intraindividual Comparison With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Baltzer PAT; Bickel H; Spick C; Wengert G; Woitek R; Kapetas P; Clauser P; Helbich TH; Pinker K
Invest Radiol; 2018 Apr; 53(4):229-235. PubMed ID: 29190227
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic performance of ultrafast MRI to differentiate benign from malignant breast lesions: a systematic review and meta-analysis.
Amitai Y; Freitas VAR; Golan O; Kessner R; Shalmon T; Neeman R; Mauda-Havakuk M; Mercer D; Sklair-Levy M; Menes TS
Eur Radiol; 2024 Mar; ():. PubMed ID: 38512492
[TBL] [Abstract][Full Text] [Related]
13. Axillary lymph node metastasis detection by magnetic resonance imaging in patients with breast cancer: A meta-analysis.
Zhou P; Wei Y; Chen G; Guo L; Yan D; Wang Y
Thorac Cancer; 2018 Aug; 9(8):989-996. PubMed ID: 29877048
[TBL] [Abstract][Full Text] [Related]
14. Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis.
Lin Z; Neiswender J; Fang B; Ma X; Zhang J; Hu X
Oncotarget; 2017 Apr; 8(16):26625-26636. PubMed ID: 28460452
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of SHOX2 promoter methylation as biomarker for lung cancer identification: A meta-analysis update.
Zhou X; Lu X; Wu H; Liu J; Huang H
Thorac Cancer; 2021 Dec; 12(24):3327-3332. PubMed ID: 34741433
[TBL] [Abstract][Full Text] [Related]
16. APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta-analysis.
Liu F; Lu X; Zhou X; Huang H
Thorac Cancer; 2021 Nov; 12(21):2907-2913. PubMed ID: 34545707
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of dynamic contrast-enhanced magnetic resonance imaging for distinguishing pseudoprogression from glioma recurrence: a meta-analysis.
Qiu J; Tao ZC; Deng KX; Wang P; Chen CY; Xiao F; Luo Y; Yuan SY; Chen H; Huang H
Chin Med J (Engl); 2021 Oct; 134(21):2535-2543. PubMed ID: 34748524
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of the nerve root sedimentation sign in lumbar spinal stenosis: a systematic review and meta-analysis.
Wang G; Peng Z; Li J; Song Z; Wang P
Neuroradiology; 2019 Oct; 61(10):1111-1121. PubMed ID: 31363807
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted imaging in monitoring the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis.
Gao W; Guo N; Dong T
World J Surg Oncol; 2018 Jul; 16(1):145. PubMed ID: 30021656
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-21 was a promising biomarker for lung carcinoma diagnosis: An update meta-analysis.
Wang H; Xu J; Ding L
Thorac Cancer; 2022 Feb; 13(3):316-321. PubMed ID: 34837469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
